These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 32490513)

  • 1. Inhibition of ROCK2 alleviates renal fibrosis and the metabolic disorders in the proximal tubular epithelial cells.
    You R; Zhou W; Li Y; Zhang Y; Huang S; Jia Z; Zhang A
    Clin Sci (Lond); 2020 Jun; 134(12):1357-1376. PubMed ID: 32490513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial deletion of the ROCK2 protein fails to reduce renal fibrosis in a unilateral ureteral obstruction model in mice.
    Baba I; Egi Y; Suzuki K
    Mol Med Rep; 2016 Jan; 13(1):231-6. PubMed ID: 26572751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosis.
    Prakash J; de Borst MH; van Loenen-Weemaes AM; Lacombe M; Opdam F; van Goor H; Meijer DK; Moolenaar F; Poelstra K; Kok RJ
    Pharm Res; 2008 Oct; 25(10):2427-39. PubMed ID: 18183478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.
    Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C
    J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-β1/Smad2/3 and NF-kB/NLRP3 signaling axis in mice.
    Ram C; Gairola S; Syed AM; Kulhari U; Kundu S; Mugale MN; Murty US; Sahu BD
    Life Sci; 2022 Jun; 298():120527. PubMed ID: 35378138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing cGMP-dependent protein kinase activity attenuates unilateral ureteral obstruction-induced renal fibrosis.
    Cui W; Maimaitiyiming H; Qi X; Norman H; Zhou Q; Wang X; Fu J; Wang S
    Am J Physiol Renal Physiol; 2014 May; 306(9):F996-1007. PubMed ID: 24573388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis.
    Lee J; Hwang I; Lee JH; Lee HW; Jeong LS; Ha H
    Am J Pathol; 2013 Nov; 183(5):1488-1497. PubMed ID: 24001475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Icariin alleviates renal inflammation and tubulointerstitial fibrosis via Nrf2-mediated attenuation of mitochondrial damage.
    Ding N; Sun S; Zhou S; Lv Z; Wang R
    Cell Biochem Funct; 2024 Apr; 42(3):e4005. PubMed ID: 38583082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress.
    Ren Y; Du C; Shi Y; Wei J; Wu H; Cui H
    Int J Mol Med; 2017 May; 39(5):1317-1324. PubMed ID: 28339034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
    Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
    Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction.
    Qiao X; Wang L; Wang Y; Zhao N; Zhang R; Han W; Peng Z
    Nephrology (Carlton); 2015 Nov; 20(11):820-31. PubMed ID: 26014968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dicer deficiency in proximal tubules exacerbates renal injury and tubulointerstitial fibrosis and upregulates Smad2/3.
    Ma Z; Wei Q; Zhang M; Chen JK; Dong Z
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1822-F1832. PubMed ID: 30280598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
    Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
    Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine kinase 1 protects renal tubular epithelial cells from renal fibrosis via induction of autophagy.
    Du C; Ren Y; Yao F; Duan J; Zhao H; Du Y; Xiao X; Duan H; Shi Y
    Int J Biochem Cell Biol; 2017 Sep; 90():17-28. PubMed ID: 28733250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of LMCD1 ameliorates renal fibrosis by blocking the activation of ERK pathway.
    Yu R; Tian M; He P; Chen J; Zhao Z; Zhang Y; Zhang B
    Biochim Biophys Acta Mol Cell Res; 2022 Apr; 1869(4):119200. PubMed ID: 34968577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvacrol preserves antioxidant status and attenuates kidney fibrosis
    Ram C; Gairola S; Syed AM; Verma S; Mugale MN; Sahu BD
    Food Funct; 2022 Oct; 13(20):10587-10600. PubMed ID: 36156620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway.
    Wang W; Ma BL; Xu CG; Zhou XJ
    Phytomedicine; 2020 Apr; 69():153185. PubMed ID: 32120244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent activation of autophagy in kidney tubular cells promotes renal interstitial fibrosis during unilateral ureteral obstruction.
    Livingston MJ; Ding HF; Huang S; Hill JA; Yin XM; Dong Z
    Autophagy; 2016 Jun; 12(6):976-98. PubMed ID: 27123926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of TRPM2 reduces renal fibrosis and inflammation through blocking TGF-β1-regulated JNK activation.
    Wang Y; Chen L; Wang K; Da Y; Zhou M; Yan H; Zheng D; Zhong S; Cai S; Zhu H; Li Y
    Biomed Pharmacother; 2019 Dec; 120():109556. PubMed ID: 31655312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis.
    Lok SWY; Yiu WH; Li H; Xue R; Zou Y; Li B; Chan KW; Chan LYY; Leung JCK; Lai KN; Tang SCW
    Clin Sci (Lond); 2020 Nov; 134(21):2873-2891. PubMed ID: 33078834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.